Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.

NCT07107529 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

150

Enrollment

NETWORK

Sponsor class

Conditions

Multiple Myeloma (MM)

Interventions

DRUG: Teclistamab
DRUG: Talquetamab
DRUG: Daratumumab

Sponsor

European Myeloma Network B.V.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]